CDMO Excellence
Delivering CDMO Excellence, Quality, and Value through Dedication
Adriana Kiędzierska–Mencfeld, Ph.D.
Rezon Bio
PAO-12-25-CL-01Dec 2, 2025
Biosimilars
Biosimilars at a Crossroads: Will the FDA’s New Framework Deliver Competition?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-25-NI-04Nov 14, 2025
CDMO
Efficiency by Design: Meeting the Evolving Challenges of a Maturing Global Biologics Market
Felix Faupel
Rezon Bio
PAO-11-25-CL-06Nov 13, 2025
Insulin
Project Insulin: Rebuilding Insulin Access for Patients, Not Profit
David Alvaro, Ph.D.; Eric Moyal
Pharma's Almanac
PAO-09-25-CL-01Sep 16, 2025
Biosimilars
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-01Mar 2, 2025
Large Molecule
Managing Pharmacovigilance Challenges for Biosimilars
Ivana Lisec, MPharm
PrimeVigilance
PAO-11-24-CL-05Jan 2, 2025
Biosimilars
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
Tanvex Biopharma
PR-09-24-NI-02Sep 5, 2024
Biosimilars
Biosimilars: Manufacturing and Supply Chain for Worldwide Patients
Paula Olcese
Biosidus
PAO-08-24-CL-06Aug 7, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Marcelo Criscuolo; Hugo Sotelo
Biosidus
PAO-07-24-CL-07Jul 16, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Marcelo Criscuolo; Hugo Sotelo
Biosidus
PAO-07-24-CL-06Jul 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09Jul 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Jorge Catella; Hugo Sotelo
Biosidus
PAO-07-24-CL-10Jul 16, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09Mar 13, 2024
Biotherapeutics
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
John R. Mosack
Tanvex CDMO
PAO-10-23-CL-05Nov 7, 2023
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-01Mar 7, 2023
Life Science Industrials
Filling Industry Gaps and Driving Innovation with Life Science Industrials
Sebastien Latapie; Reinhard Vogt
Dynamk Capital
PAO-11-21-CL-01Nov 3, 2021
Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra®
Biogen
PR-M06-21-010Jun 8, 2021
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Mark Woolf
Catalent
PAO-03-21-CL-06Mar 22, 2021
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
Richard Richieri
Avid Bioservices
PAO-03-21-CL-03Mar 18, 2021
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018Sep 29, 2020